Discover why Ambev S.A. is a strong buy with ultra-cheap valuations, 5%+ dividend yields, and potential for 18-24 month gains ...

The Risen Star Stakes has experienced its share of surprising finishes in its half-century history, but few have been more ...

The Trump administration's move to curtail discretionary spending for NIH research grants will help curtail out-of-control ...